Kinetics Medical Portfolio is a registered fund series of Kinetics Portfolios Trust (series S000007854). Net assets $19.2M as of 2022-12-31.
Showing 15 of 36 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co | — | $1.8M | 950.73% |
| Bristol-Myers Squibb Co | — | $1.7M | 878.81% |
| AbbVie Inc | — | $1.6M | 839.97% |
| Merck & Co Inc | — | $1.6M | 807.33% |
| Pfizer Inc | — | $1.5M | 798.96% |
| Novartis AG | — | $1.3M | 660.13% |
| Johnson & Johnson | — | $1.2M | 642.70% |
| Amgen Inc | — | $1.1M | 546.03% |
| Biogen Inc | — | $1.0M | 539.74% |
| AstraZeneca PLC | — | $881K | 458.11% |
| Gilead Sciences Inc | — | $773K | 401.59% |
| Alnylam Pharmaceuticals Inc | — | $713K | 370.56% |
| Sanofi | — | $630K | 327.23% |
| US BANK MMDA - USBGFS 7 | USBGFS7 | $575K | 299.00% |
| Alkermes PLC | — | $575K | 298.78% |
| Report date | Net assets |
|---|---|
| 2022-12-31 | $19.2M |
| 2022-09-30 | $17.0M |
| 2022-06-30 | $18.1M |
| 2022-03-31 | $18.2M |
| 2021-12-31 | $18.4M |
| 2021-09-30 | $18.3M |
| 2021-06-30 | $19.8M |
| 2021-03-31 | $17.6M |